1,087
Views
0
CrossRef citations to date
0
Altmetric
Report

A Tool for Deprescribing Antithrombotic Medication in Palliative Cancer Patients: A Retrospective Evaluation

, , , &
Pages 20-27 | Received 09 May 2023, Accepted 19 Nov 2023, Published online: 18 Dec 2023
 

Abstract

Treating palliative cancer patients with antithrombotics is challenging because of the higher risk for both venous thromboembolism and major bleeding. There is a lack of available guidelines on deprescribing potentially inappropriate antithrombotics. We have therefore created an antithrombotics scheme to aid in (de)prescribing antithrombotics. A retrospective single-center clinical cohort observational study was performed to evaluate it. Patients with solid tumors with a life expectancy of less than 3 months seen by the palliative team were included. Comparisons were made between patients who were treated according to the antithrombotics scheme and those who were not. 47.6% of patients used antithrombotics. One hundred and eleven patients were included for analysis. Most patients used antithrombotics according to the scheme (n = 80, 72.1%). Eleven patients experienced a clinical event, seven patients in the scheme adherence group (9.9%) and four in the no scheme adherence group (13.8%), which was not statistically significant (p = 0.726). The higher frequency of clinical events in the group without scheme adherence suggests that (de)prescribing antithrombotics according to the antithrombotics scheme is safe. The results of this study suggest that the antithrombotics scheme could aid healthcare professionals identifying possible inappropriate antithrombotics in palliative cancer patients. Further prospective research is needed to investigate this tool.

Acknowledgments

The authors would like to express their gratitude to K.B. Gombert-Handoko for her expertise during this research.

Ethical statement

The Medical Ethics Committee at Amsterdam UMC, location VUmc, granted approval of the study under number 2022.0493.

Authors’ contributions

All authors contributed to the study concept and design. Data collection was performed by AR. Data analysis was performed by AR, JK and MC. The manuscript was written by AR and was commented on by all authors. All authors read and approved the final manuscript.

Disclosure statement

All authors declare no conflict of interest.

Data availability statement

Based on the data use policy of Amsterdam UMC and reasonable request, the dataset is available by sending an email message to the corresponding author.

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

Regular institutional funding.